Prostate cancer treatment with exercise medicine

Abstract

Exercise can reduce the risk of death in men with prostate cancer. Although the effect was demonstrated over 10 years ago, exercise medicine is still not recognised as a critical therapy in cancer management. Nevertheless, the evidence base is building, and an ongoing randomised controlled trial has been designed to assess whether a targeted and highly sophisticated exercise medicine intervention causes a survival advantage in men with metastatic castrate-resistant prostate cancer.

RAS ID

56683

Document Type

Journal Article

Date of Publication

2022

School

School of Medical and Health Sciences / Exercise Medicine Research Institute

Copyright

free_to_read

Publisher

Wiley

Comments

Newton, R. U., Hart, N. H., Galvão, D. A., Taaffe, D. R., & Saad, F. (2022). Prostate cancer treatment with exercise medicine. Trends in Urology & Men's Health, 13(6), 14-19. https://doi.org/10.1002/tre.884

Share

 
COinS
 

Link to publisher version (DOI)

10.1002/tre.884